The Role of Th17-Related Cytokines in Atopic Dermatitis
Open accessThe DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
T helper-17 (Th17) cells, which mainly produce IL-17, are associated with development of various autoimmune diseases such as rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, and psoriasis. IL-17 and related cytokines are therapeutic targets of these diseases. In atopic dermatitis (AD), Th2 cytokines such as IL-4 and IL-13 are regarded to be the main player of the disease; however, Th17 cytokines are also expressed in AD skin lesions. Expression of IL-22 rather than IL-17 is predominant in AD skin, which is contrary to cytokine expression in psoriasis skin. Relatively low IL-17 expression in AD skin can induce relatively low antimicrobial peptide expression, which may be a reason why bacterial infection is frequently seen in AD patients. Failure of clinical trials for investigating the efficacy of anti-IL-12/23 p40 in AD has suggested that IL-17 expressed in skin lesions should not be the main player but a bystander responding to barrier dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Proliferation of epidermal cells, AMP expression, vascular formation, and infiltration of Th17, neutrophils, and macrophages, commonly seen in wounded skin and in psoriasis skin. We sometimes experience fungal infection in patients treated with anit-IL7A or anti-IL17 receptor A antibody. Considering that Th17 cytokines are expressed in various skin diseases with barrier dysfunction and that antibodies against IL-12/IL-23p40 or IL-17A are not effective for AD, IL-17 and its related cytokine expression can be regarded as a common defense mechanism in the skin. Relatively low AMP expression leads to a higher risk of infection seen in AD and CTCL [77,78]. Targeting the Th17 cytokine has been successful for psoriasis, but may not be always the case in other skin diseases.](https://figures.cochat.ai/paper-figures/ed84282be6714f7887f1a44756b5fdc2/the-role-of-th17-related-cytokines-in-atopic-dermatitis-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of these receptors by PAHs can lead to disruption of the skin barrier and skewing of the immune response towards a Th2 phenotype, which is central to the development and progression of AD [23–25].”
From The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 1×
“Th17 cells, which are different from Th1 or Th2 cells, produce IL-17, IL-17F, and IL-22 as well as IL-21 [21].”
BackgroundDefensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066 · cited 1×
“IL-17 also increases production of antimicrobial peptides (AMPs), which are part of the innate immune response and are found among all classes of life [30,31].”
BackgroundHuman epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183 · cited 4×
“The intrinsic type is characterized by the lower expression of IL-4, IL-5, and IL-13, and the higher expression of IFN-γ.”
BackgroundInfluentialLeonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Blauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261 · cited 2×
“Cytokines Clinical Response References IL-17A Worsening of dermatitis [57–59] IL-12/23p40 No effect in clinical trial [55,56] IL-22 Effective for some patients [60,61] IL-4/13 Very effective [68]”
BackgroundSonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044 · cited 2×
“IL-22, which is another cytokine expressed by Th17, enhances AMP production together with IL-17 [31].”
BackgroundA role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Cited by
Items 101–200 of 204
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report
Gelato, F., Mastorino, L., Cavalla, P., Quaglino, P., Cavaliere, G., Vercellino, M., Bosa, C., Inglese, M., Palma, R. D., Ortoncelli, M., et al. (2022) · Dermatologic Therapy · doi:10.1111/dth.15740 · Cited by 8
“1 It has also been reported that Th17-related cytokines (IL-17 and IL-22) and Th1 cytokines such as interferon-γ (INFγ) play a minor role in the pathogenesis of AD.2 Recent studies have shown that IL-4 has a negative regulatory action on the Th1 and Th17 pathway by silencing of IL-23 in antigenpresenting cells.3 In MS…”
BackgroundSung, M., Sim, S., Lim, A., Moon, J. S., Jeon, J. I., Heo, K., Kwak, W., Park, M. S., Kwak, J., Park, E., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13081950 · Cited by 7
“AD is a chronic inflammatory skin condition characterized by excessive activation of Th2 immune responses, leading to IgE-mediated mast cell degranulation and increased secretion of pro-inflammatory cytokines, including IL-4, IL-5, and IL-13 [1–3].”
InfluentialMartin, B., Schepmann, D., Bernal, F. A., Schmidt, T. J., Che, T., Loser, K., & Wünsch, B. (2020) · ChemMedChem · doi:10.1002/cmdc.202000300 · Cited by 9
Xiong, H., Yang, J. P., Liu, T., Liu, G., Han, Y., & Dong, X. (2022) · Mediators of Inflammation · doi:10.1155/2022/6206883 · Cited by 7
“IL-17 can induce the expression of various proinflammatory cytokines, such as IL-6 and IL-8, which leads to increased T cell migration to the skin [31].”
BackgroundIL-17 family cytokines in inflammatory or autoimmune skin diseases
Kong, B., & Lai, Y. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.07.002 · Cited by 8
IL-17 in skin infections and homeostasis
García-Patiño, M. G., Marcial-Medina, C., Ruiz-Medina, B. E., & Licona-Limón, P. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110352 · Cited by 11
JAK inhibitors as a promising therapy for immune-mediated photodermatoses
Malekan, M., Taghiloo, S., Kazeminejad, A., Gholizadeh, N., Montazer, F., & Rokni, G. R. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104344 · Cited by 7
Wang, R., Nakajima‐Adachi, H., Wang, Y., Zhou, Y., Gu, W., Hiraide, E., Morinaga, M., Nakagawa, R., Nakamura, S., Takano, T., et al. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105091 · Cited by 7
Unlocking the molecular pathway of atopic dermatitis: journey so far and roads ahead
Kumar, S., Sharma, R. R., Komal, K., Kumar, D., Ghosh, R., & Kumar, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01900-0 · Cited by 8
“Furthermore, the Th1-inducing cytokine ILK-12, which has been notified as pathogenic in various mouse models of inflammatory diseases, ILK-23 plays a critical role in Th1 cells (Sugaya 2020).”
Шмарина, Г. В., Pukhalskaya, D. A., Shmarin, V., Semykin, S. Y., Avakyan, L. V., Krasovsky, S. A., Goryainova, A., Kostyuk, S. V., Zinchenko, R. A., & Kashirskaya, N. Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1374318 · Cited by 7
“These data are consistent with past researches showing the role of IL-17 cytokines in development of in fl ammatory disorders including allergic rhinitis (Gu et al., 2017), bronchial asthma (Sorbello et al., 2015), dermatitis (Sugaya, 2020) and arthritis (Miossec, 2021) as well.”
ResultWan, H., Yang, H., Wei, M., & Chen, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-282 · Cited by 7
“The T-helper 2 (Th2) pathway arm of the adaptive immune response is currently thought to be the primary driver of AD-related pathology, with substantial contributions from the Th1, Th17, and Th22 axes and from the JAK/ STAT signaling pathways (4-7).”
BackgroundPezzolo, E., Sechi, A., Tartaglia, J., & Naldi, L. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2283585 · Cited by 6
“As a matter of fact, the role of Th17-cytokines in AD inflammation is controversial, though their presence has been suggested to be part of a response against Staphylococcus aureus [16].”
BackgroundNasehi, P., Omidkhah, N., & Ghodsi, R. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108950 · Cited by 7
Lu, C., Zeng, Y., Wang, G., Lou, B., Wang, Y., Wh, L., Yan, Z., & Fu, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1685708 · Cited by 5
“Elevated levels of IL-17, a cytokine produced by Th17 cells, are found in the peripheral blood of AD patients and correlate with more severe disease (Sugaya, 2020).”
Atopic dermatitis is associated with the clinical course of inflammatory bowel disease
Kim, K. W., Koh, S., Kang, H. W., Park, H., Ha, H., Park, J., Kim, K., Jun, Y., Han, Y. M., Lee, H. J., et al. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2209688 · Cited by 5
“In addition, the number of Th17 cells are higher in the Asian AD patients, compared to that in European or American patients [25].”
BackgroundResultJing-Fang powder ethyl acetate extracts attenuate atopic dermatitis by modulating T-cell activity
Zhao, G., Tong, Y. A., Xu, J., Zhu, W., Zeng, J., Liu, R., Luan, F., & Zeng, N. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.07.002 · Cited by 5
The role of lipocalin-2 in the pathophysiology of hidradenitis suppurativa
Miše, J., Marinović, B., & Mokoš, Z. B. (2025) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2025.05.006 · Cited by 5
The role of interleukin-24 in atopic dermatitis
Vu, Y. H., Furue, M., & Tsuji, G. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00002 · Cited by 7
“The Th2-type cytokines IL-4, IL-13, and IL-31 It is widely accepted that the Th2 cytokines IL-4 and IL-13 are driving factors in AD pathogenesis, as the blockade of IL-4/IL-13 signaling by dupilumab is effective in patients with severe AD [30].”
BackgroundSystemic treatments in atopic dermatitis in children
Gürel, D. İ., Soyer, Ö., & Şahiner, Ü. M. (2023) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2023.203 · Cited by 8
Kim, H. S., Ahn, J. W., Ha, N. R., Damodar, K., Jang, S. K., Yoo, Y., Gyoung, Y. S., & Joo, S. S. (2024) · Marine Drugs · doi:10.3390/md22080354 · Cited by 6
“Conversely, IL-22 is implicated in chronic pruritus and disrupting the skin barrier function, which exacerbates sensitization to allergens and contributes to the cycle of inflammation and itching symptoms of AD [36,37].”
BackgroundAtopic disease and inflammatory bowel disease: A bidirectional Mendelian randomization study
Zheng, D., Xu, Q., & Liu, Y. (2024) · Medicine · doi:10.1097/md.0000000000040143 · Cited by 5
“37] Additionally, Th17 cells are implicated in the pathogenesis of IBD.”
BackgroundKim, B.-G., & Park, M. K. (2022) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2022.14.1.5 · Cited by 5
Woźniacka, R., Lechowska-Liszka, A., Stenka, B., Bac, A., Homa, J., Chadzińska, M., & Ścisłowska‐Czarnecka, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212099 · Cited by 4
Elfadadny, A., Samir, H., Mandour, A. S., Ragab, R. F., Elshafey, B. G., Alanazi, F. E., Hetta, . F., Alharbi, A. A., Albalawi, A. S., Al-Jameel, S. S., et al. (2025) · Animals · doi:10.3390/ani15030411 · Cited by 4
“Th17 cells have been explored as crucial players in AD in mouse models [5,7].”
Luo, J., Li, C., Zhu, Y., Guo, R., Huang, J., Yu, H., Sun, M., Zhu, Q., Guo, Q., Li, Y., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152028 · Cited by 4
Simultaneous targeting of multiple etiological using a nanosized strategy for psoriasis management
Jiang, X., Wang, M., Zhang, L., Huang, Z., Mao, P., Zhao, Y., Tao, Z., Han, Y., Cai, L., Zhang, K., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102593 · Cited by 4
“Given the pivotal role of CD4 + T cells in psoriatic immunopathology [88], and the well-documented elevation of Th17-related cytokines in both psoriatic lesions and patient serum [89], we further assessed the Th17 response.”
Binsaleh, A. Y., Kotkata, F. A., Bahaa, M. M., Hamouda, A. O., El‐Gammal, M. A., Elberri, A. I., Selim, H. M., El‐samongy, M. A., Hamouda, M. A., Mokhtar, F. A., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70028 · Cited by 5
The role of the aromatic hydrocarbon receptor in the pathogenesis of atopic dermatitis
Gorodnichev, P. V. (2023) · Vestnik dermatologii i venerologii · doi:10.25208/vdv4775 · Cited by 4
Torrealba, M. P., Yoshikawa, F. S. Y., Aoki, V., Sato, M. N., & Orfali, R. L. (2024) · Microorganisms · doi:10.3390/microorganisms12030531 · Cited by 4
“Although AD is a disease ruled by type 2 immune responses (Th2, IL-4 and IL-13 Although AD is a disease ruled by type 2 immune responses (Th2, IL-4 and IL-13), IL-17 contributes to the worsening of the symptoms by enhancing IL-4 production from Th2 cells [51].”
BackgroundHu, Y., Zhao, Y., & Zhang, J. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s430915 · Cited by 5
Lee, C.-L., Wang, C.-M., Lu, S., Song, Y., Chiang, H., Liao, H., & Yen, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120268 · Cited by 3
Advances of bispecific antibodies using/application in dermatology: a review
Zhang, T., Yang, J., Liew, P. X., Zhang, Y., & Zhao, Z. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1668931 · Cited by 3
“On the other hand, Th17 cytokines such as IL-17 and IL-22 also play important roles in the chronic stage of atopic dermatitis, promoting the damage of the skin barrier function and the persistence of in fl ammation (26).”
Čelakovská, J., Čermáková, E., Boudková, P., & Andrýs, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1748929 · Cited by 3
Implication of T Helper Cytokines in Contact Dermatitis and Atopic Dermatitis
Cochez, P. M., Choteau, M., Limaye, N., Baeck, M., & Dumoutier, L. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00263-x · Cited by 3
Identification of immune-related hub genes in spinal cord injury
Gao, X., Su, Y., Shan, S., Qian, W., & Zhang, Z. (2024) · European journal of medical research · doi:10.1186/s40001-024-02075-0 · Cited by 3
“Th17 cells can produce the pro-inflammatory cytokine IL-17 and play a significant role in immune responses [32].”
BackgroundNakajima, H., Kamata, M., Okada, Y., Suzuki, S., Ito, M., Watanabe, A., Egawa, S., Chijiwa, C., Hiura, A., Tomura, Y., et al. (2024) · Experimental Dermatology · doi:10.1111/exd.70010 · Cited by 4
Choi, Y., Fan, M., Yu, Y., Wang, X., Tang, Y., & Kim, E. (2020) · Animal Production Science · doi:10.1071/an19500 · Cited by 3
Serum interleukin 38 (IL-38) as a new potential biomarker of pediatric asthma
Kamal, A., Basanti, C. W. S., Kaushty, M. A., & Abdelmegeid, A. K. (2022) · Egyptian Journal of Bronchology · doi:10.1186/s43168-022-00139-5 · Cited by 3
Lezmi, G., Poirault, C., Grauso, M., Dietrich, C., Adel‐Patient, K., & Leite‐de‐Moraes, M. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104815 · Cited by 3
Boudková, P., Čermáková, E., Krejsek, J., & Čelakovská, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112327 · Cited by 3
The Skin Histopathology of Pro- and Parabiotics in a Mouse Model of Atopic Dermatitis
Kim, H. H., Jeong, S. H., Park, M. Y., Bhosale, P. B., Abusaliya, A., Heo, J., Kim, H., Seong, J. K., Kim, T. Y., Park, J. W., et al. (2024) · Nutrients · doi:10.3390/nu16172903 · Cited by 5
Mechanistic Evaluation of EGCG against Atopic Dermatitis: An in Vivo and in Silico Study
Tang, L., Wang, T., Peng, R., Guo, J., Li, L., Zhou, B., Luo, G., Fang, S., & Jiang, X. (2024) · Natural Product Communications · doi:10.1177/1934578x241304962 · Cited by 6
“34,35 The “ EGCG-target-pathway network ” , which re fl ects correlations between the crucial pathways and the common targets of EGCG, suggest that EGCG might treat AD by acting on multiple molecular targets and biological pathways.”
Atopic Dermatitis Severity and Risk for Psoriasis: A Nationwide Population-Based Study
Lee, H. J., Hong, Y. J., Han, K., & Lee, J. H. (2024) · Dermatology · doi:10.1159/000536143 · Cited by 4
“IL-17, well known to play an important role in AD and psoriasis, activates macrophages to express tumor necrosis factor-α and IL-1 β and fi broblasts to produce IL-6, IL-8, and matrix metalloproteinases [12].”
BackgroundZhen, L., Chen, Y., Gao, J., Li, B., & Jia, Y. (2023) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023050312 · Cited by 2
Wan, M., & Yang, X. (2024) · International Archives of Allergy and Immunology · doi:10.1159/000542777 · Cited by 2
“These cells in fi ltrate the skin lesions of AD and produce cytokines like interleukin (IL)-17, IL-22, and tumor necrosis factor-α which contribute to the in fl ammatory process [33].”
Tian, X., Li, J., Xu, H., Liang, J., Yang, Y., Gao, A., Zhao, X., Shao, L., Zhang, J., Ye, Q., et al. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12888 · Cited by 2
“Th17 cell subsets may have a less critical role in the pathogenesis of AD and could exert protective effects, helping to regulate the skin's immune response and maintain the skin's health status (12).”
Pramanik, A., Mondal, P., & Bhattacharyya, S. (2025) · Biomolecules · doi:10.3390/biom15111543 · Cited by 2
“While traditionally viewed as a primarily T helper type 2-mediated disease driven by cytokines like IL-4 and IL-13 [110,111], recent research indicates a more intricate immune landscape, with T helper 17 cells and their associated cytokines, particularly IL-17, also contributing to AD pathogenesis…”
Trimarchi, M. P., Namjou‐Khales, B., Morgenstern, N. B.-B., Rochman, M., Chen, X., Osswald, G. A., Besse, J. A., Shook, M., Caldwell, J. M., Lape, M., et al. (2026) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2026.03.008 · Cited by 3
Tang, W., Liao, C.-Y., Xu, H. M., Huang, W., Wu, Z.-X., Chen, T., Liu, T. C., & Wang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1846799 · Cited by 2
“This multi-cellular, multi-factor synergistic action has been associated with the typical Th2/Th17 mixed in fl ammatory response seen in AD, accompanied by a signi fi cant elevation in both total serum IgE and levels of IgE speci fi c to SEVs (80, 84, 85).”
Precision medicine in atopic dermatitis
Fonacier, L. S., Mawhirt, S. L., Stern, H. H., Roellke, E., Singer, S., Hunt, A., & Lio, P. (2026) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2026.06.006 · Cited by 2
Genetically predicted endogenous sex hormone levels with risk of eczema or dermatitis
Zeng, M., Yang, D. S., & Chen, Y. (2024) · HORMONES · doi:10.1007/s42000-024-00616-0 · Cited by 2
“Eczema or dermatitis affects approximately 20% of children and up Hormones (2025) 24:199–205 in AD skin lesions [7].”
Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
Steinhoff, M. S., Adeli, M., Riad, H., Allam, M., Hazem, A., Alsmadi, R., Kamal, A. M., Ibrahim, W., & Al‐Nesf, M. A. (2023) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2251622 · Cited by 2
“The Th2-mediated inflammation releases IL-4, IL-13, and IL-31 that interrupt the barrier of the skin (27).”
BackgroundHost Immune Response to Scabies
Taylor, S., Hales, B. J., & Thomas, W. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-26070-4_4 · Cited by 3
The relationship between umbilical cord blood IL-22 level and infantile eczema at 42 days
Lu, X., Wang, W., Wang, Y., Huan, C., & Yang, Y. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1376706 · Cited by 2
“The levels of IL-22 in the skin of children with eczema are considerably higher than in adults and correlate signi fi cantly with disease activity (25).”
BackgroundExploring novel drug targets for atopic dermatitis through plasma proteome with genome
Wu, W., Su, H., Chen, Z., & Wei, S. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03262-z · Cited by 3
“Given the crucial role of the Th17 pathway in AD, this suggests a potential role for MMP12 in the condition [ 53 ].”
Li, X.-Y., Pan, L., Deng, Y.-W., Chen, J., Tian, Z., Tang, G., Ge, S., & Wang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551311 · Cited by 2
Immune system in development and progression of viral myocardial damage
Khegai, I. M., Trunina, I. I., Chebotareva, T. A., Khodikyan, G. K., & Валентинович, Ш. П. (2021) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2021-66-3-27-33 · Cited by 3
Dvornikov, A. S., Gusev, E. I., Martynov, M. Y., Lashch, N. Y., Gaydina, T. A., Сергеевна, Ч. А., & Boyko, A. N. (2024) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn12461 · Cited by 2
Анатольевич, В. И., Teryaev, A. S., Gladko, O. V., Rebrova, O. M., Павловна, М. А., & Makarova, A. G. (2023) · Bulletin of the Medical Institute of Continuing Education · doi:10.36107/2782-1714_2023-3-3-8-13 · Cited by 2
Wang, Y., Yin, H., Li, Z., Wu, H., Wang, Q., Chen, X., Mao, L., Wu, Y., Wang, S., Qin, H., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.02.145 · Cited by 1
The Supporting Role of Hyperbaric Oxygen Therapy in Atopic Dermatitis Treatment
Zwoliński, M., Hovagimyan, A., Ignatowicz, J., Stelmasiak, M., Lewicka, A., Bień, J., Bałan, B. J., & Lewicki, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093138 · Cited by 2
“…IL-22, and tumour necrosis factor-alpha Th17 cells secrete IL-17A, IL-17F, IL-22, and tumour necrosis factor-alpha (TNF-α ), further contributing to skin inflammation and barrier dysfunction [29]. factor-alpha (TNF-α ), further contributing to skin in fl ammation and barrier dysfunction [29].”
Lin, T.-C., Wu, Y., Tsai, Y., Lin, S.-W., Chen, C., Chen, M., & Chen, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1566594 · Cited by 1
“Regarding IL-17, produced by Th17 cells, it plays a crucial role in the immune defense against allergies (Sugaya, 2020).”
Xu, Y., Hashimoto, N., Kano, F., Xia, L., Ding, C., Lao, H., Wang, Y., Arai, T., Iwasaki, T., & Yamamoto, A. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04735-2 · Cited by 1
“They secrete IL-17 and IL-22, which disrupt the skin barrier, enhance inflammation, and recruit neutrophils [6].”
Secretome as a novel regenerative strategy for atopic dermatitis: a comprehensive review
Subramaniam, P., Shafiee, M. N., Fadilah, N. I. M., Fauzi, M. B., & Maarof, M. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04891-5 · Cited by 1
Zhang, T., Cao, C., Zhang, L., Lina, J., Wang, Q., Qingli, L., Hu, J., Du, W., Xu, Y., Liu, J., et al. (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/6215711 · Cited by 1
Takada, M., Sashikawa, M., Ohno, Y., Hossain, M. R., Xie, X., Iwabuchi, K., Komine, M., Ohtsuki, M., & Imokawa, G. (2026) · The Journal of Pathology · doi:10.1002/path.70050 · Cited by 1
“IL17A triggers DAMP expression, suggesting that S100A8 and S100A9 induce DAMP-mediated in fl ammation in AD [63] and respond to barrier dysfunction [67].”
Zeng, Y., & Feng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1837198 · Cited by 1
“…LL-37 further ampli fi es the pathology of rosacea through three coupled mechanisms (1): NLRP3 axis: LL-37 triggers NLRP3 assembly and promotes caspase-1-mediated the maturation and release ofIL-1 b and IL-18 (71), thereby stimulating T-cell proliferation and Th 17 differentiation (72, 73) (2).”
Biological drugs for the treatment of children with atopic dermatitis
Giovannini, M., Vecillas, L. D. L., Filippo, M. D., Castagnoli, R., Votto, M., Klain, A., Dinardo, G., Trincianti, C., Marseglia, G. L., Indolfi, C., et al. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2693204 · Cited by 1
“Similarly, recent studies showing elevated Th17-related cytokines (IL-17 and IL-23) in AD lesional skin suggest a potential role in AD pathogenesis of Th17 signaling [10].”
Tang, F., Liu, S., Cheng, F., Wang, Q., & Wang, X. (2022) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2022.09.003 · Cited by 1
Woo, Y. R., Choi, A., Song, S., Kim, S., Cho, S. H., Cho, S. H., Kim, J. E., & Kim, J. E. (2024) · Annals of Dermatology · doi:10.5021/ad.23.099 · Cited by 1
“…helper-17 (Th17) immune activation, an important pathway in hypertension 28 , is also implemented in the pathogenesis of AD and especially in Asian 29,30 , and thereby this shared immune pathway in both conditions along with other inflammatory mediators could contribute to the increased risk of…”
BackgroundOkubo, Y., Kobayashi, S., Murakami, M., Sano, S., Kikuta, N., Ouchi, Y., & Terui, T. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00896-7 · Cited by 1
Budair, F. M., AlHemli, H. A., Zeidan, A. A., Alshehri, A., Alratroot, J. A., & Hasan, M. A. (2024) · Electronic Journal of General Medicine · doi:10.29333/ejgm/15521 · Cited by 1
“However, since the reaction type has an immune-mediated nature, and subsided after the discontinuation of anti-IL17a, it could be considered paradoxical eczema [23].”
BackgroundThe Twins-Hit Hypothesis of Atopic Dermatitis and Autoimmune Diseases
Alraddadi, M. O., & Alhazmi, K. A. (2021) · World Journal of Environmental Biosciences · doi:10.51847/i74xneqidk · Cited by 1
“Also, there is increasing evidence that the disease is increasing in the adult population and not only a disease of childhood (Sugaya, 2020).”
BackgroundSung, B., Baek, Y.-Y., Kim, Y., & You, J. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113498 · Cited by 1
“increased in AD, although its role is still controversial and is not as important as in psoriasis [25].”
BackgroundThe Antioxidant and Immunomodulatory Potential of Coccoloba alnifolia Leaf Extracts
de Melo, L. F. M., Barbosa, J. D. S., Cordeiro, M. L. D. S., Aquino-Martins, V. G. D. Q., da Silva, A. P., Paiva, W. D. S., Silveira, E. R., dos Santos, D. Y. A. C., Rocha, H. A. O., & Scortecci, K. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115885 · Cited by 1
Acharya, M., Gautam, R., Yang, S., Jo, J., Maharjan, A., Lee, D., Ghimire, N. P., Min, B., Kim, C., Kim, H., et al. (2024) · Laboratory Animal Research · doi:10.1186/s42826-024-00201-x · Cited by 2
“Even though controversial results reported, IL-17 has been reported more often to be highly expressed in aAD stage but downregulated in cAD stage [32, 33].”
ResultZhou, W., Li, A., Zhang, C., Chen, Y., Li, Z., & Lin, Y. (2022) · medRxiv · doi:10.1101/2022.04.04.22273382 · Cited by 1
Biomarkers of atopic dermatitis: a meta-analysis over the last decadePreprint
Lyu, A., Lyu, H.-L., Wu, C.-X., & Shan, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2363344/v1 · Cited by 1
Popescu, F., Jutel, M., & Smolińska, S. (2024) · Preprints.org · doi:10.20944/preprints202410.1966.v1 · Cited by 1
Trimarchi, M. P., Namjou, B., Morgenstern, N. B.-B., Rochman, M., Chen, X., Osswald, G. A., Besse, J. A., Shook, M., Caldwell, J. M., Lape, M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6630283/v1 · Cited by 2
AL-Hasnawi, S. M. J., & Al-khayat, D. H. J. (2022) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.16.3.22
Advances in Cellular Immune Mechanisms of Atopic Dermatitis
(2023) · International Journal of World Medicine · doi:10.38007/ijwm.2023.040210
“One study showed that AD patch test sites are infiltrated with more IL-17 cytokine than healthy skin, and its expression in AD skin can induce relatively low AMP expression, which may account for the frequent bacterial infections in AD patients [21,22].”
Mind bomb 2 limits inflammatory dermatitis in Sharpin mutant mice independently of cell death
Simpson, D. S., Anderton, H., Yousef, J. M., Vaibhav, V., Cobbold, S. A., Bandala‐Sanchez, E., Kueh, A. J., Dagley, L. F., Herold, M. J., Silke, J., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad438
“Injection of IL-23 is sufficient to induce psoriasis in mice that is partially dependent on TNF (35) and clinical trials have demonstrated that biologics against IL-23 are efficacious in patients with moderate to severe psoriasis (36, 37).”
BackgroundRosso, J. Q. D. (2024) · Clinical Cases in Dermatology · doi:10.1007/978-3-031-52147-8_20
Xie, Y., Liu, H., Qiu, Y., & Cao, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4992688/v1
Xu, Z., Zhou, B., Wu, S., Yu, T., & Li, L. (2024) · European Journal of Inflammation · doi:10.1177/1721727x241297442
“…of the case and control subjects for studies with gene polymorphisms 4 ; sample size of both groups 5 ; TSLP genotype frequencies or levels of both groups 6 ; units and methods of detection for studies with levels 7 ; results of Hardy Weinberg Equilibrium (HWE) for studies with polymorphisms.”
Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways
Macharadze, D. S. (2024) · Medical Immunology (Russia) · doi:10.15789/1563-0625-pro-3070
Trimarchi, M. P., Namjou, B., Morgenstern, N. B.-B., Rochman, M., Chen, X., Osswald, G. A., Besse, J. A., Shook, M., Caldwell, J. M., Lape, M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6630283/v2 · Cited by 2
JAK inhibitors in atopic dermatitis
Gellén, E., Korponai, J., Tári, V., Sajtos, L., & Szegedi, A. (2025) · Bőrgyógyászati és Venerológiai Szemle · doi:10.7188/bvsz.2025.101.2.2
Genetic and Immunological Determinants of Atopic Dermatitis: A Systematic Review
Lisiecka, M. Z. (2025) · International Journal of Child Health and Nutrition · doi:10.6000/1929-4247.2025.14.04.4
Guan, J., Li, Y., Lu, F., & Feng, J. (2022) · Figshare · doi:10.6084/m9.figshare.19321399
Acharya, M., Gautam, R., Yang, S., Jo, J., Maharjan, A., Lee, D., Ghimire, N. P., Min, B., Kim, C., Kim, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25558933
Guan, J., Li, Y., Lu, F., & Feng, J. (2022) · Figshare · doi:10.6084/m9.figshare.19321396
NUHURRIDHA, W., Ilyas, F. S., Adriani, A., Tawali, S., Djawad, K., & Sjahril, R. (2026) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.25.05940-6
Lefèvre‐Utile, A. (2021) · theses.fr (ABES) · doi:10.70675/e862df74z545az4e0bza70az48ee9411c538
iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice
Guo, P., Cui, H., Wang, B., Shi, L., Li, F., Di, Y., Wang, S. Y., Zhang, B., Li, X., & Hu, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116750
Kendall, A. C., Mohamed, K., Linley, H., Koszyczarek, M. M., Chandidzura, A., Griffiths, C. E. M., Hussell, T., Saunders, A., & Nicolaou, A. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70467
“IL‐17 plays a crucial role in psoriasis [34], and is implicated in atopic dermatitis [53] and seborrhoeic dermatitis [54] demonstrating its crucial role in skin inflammation.”
Recent Progress in Extracellular Vesicles Therapeutics for Atopic Dermatitis Treatment
Jeong, S., Kim, H. J., Oh, M. J., Song, Y., Kim, J., Kim, T. G., Shin, Y. J., Cho, S. H., Park, J. M., Park, M., et al. (2026) · BioChip Journal · doi:10.1007/s13206-026-00273-y
“In acute AD lesions, Th2 cytokines like IL-4, IL-5, and IL-13 are predominantly expressed [6–8], inducing IgE production in B cells and eosinophil activation while suppressing skin barrier protein expression [197–199].”
Liu, Y., Yin, M., Yang, Y., Heng, S., Zhang, W., Song, J. H., Feng, B., Yang, Y., Liu, W. J., & Zhang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1875876
“Although IL17 has also been reported to participate in AD disease pathogenesis (32 – 34), these pleiotropic genes are regulated by multiple in fl ammatory cascades, and their downregulation likely re fl ects broad-spectrum anti-in fl ammatory activity rather than speci fi c Th17 inhibition.”
Metadata
- Authors
- Sugaya, M.
- Affiliations
- International University of Health and Welfare Ichikawa Medical Center (JP)
- Corresponding author
- Sugaya, Makoto
- ORCID
- Sugaya, Makoto
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-15
- Volume
- 21
- Issue
- 4
- Pages
- 1314
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7072946
- OpenAlex
- W3006169882
- Semantic Scholar
- 1393156b84cfca45fd4122ed4220e8af97991f3b
- Cited by
- 204
- References
- 84
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 48 · 2023: 32 · 2022: 42 · 2021: 23 · 2020: 12
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- atopic dermatitis, Th17 cells, IL-17, IL-22, Th2 cytokines, IL-4, IL-13, antimicrobial peptides, bacterial skin infections, skin barrier dysfunction, IL-12/23p40, psoriasis
- MeSH terms
- Interleukin-22, Dermatitis, Atopic, Humans, Interleukins, Skin, Keratinocytes, Interleukin-4, Cytokines, Interleukin-13, Interleukin-17, Antimicrobial Cationic Peptides, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.